American Neuro Technology Company

Neurotechnology/Biotechnology

Founded: 2016

Neuralink, founded in 2016, is a leading neurotechnology and biotechnology company based in the United States. The company is focused on developing advanced brain-machine interface technologies to create a direct connection between the human brain and computers. This groundbreaking technology aims to help people with neurological disorders, improve cognitive abilities, and eventually enable seamless communication with artificial intelligence systems.

Neuralink's core mission is to leverage its innovative neurotechnology to improve the quality of life for individuals suffering from a range of medical conditions, such as paralysis, Alzheimer’s, and other brain-related diseases. The company's ultimate goal is to integrate human consciousness with AI, potentially revolutionizing the future of human interaction and technology.

Connect With Us Today

Interested in learning more about exclusive pre-IPO investments? Contact our team to start exploring opportunities in technology-driven markets.

Our network of third party funds are only available for accredited investors, the SEC defines an accredited investor as:

Financial Criteria

  • Individuals (i.e., natural persons) may qualify as accredited investors based on wealth and income thresholds, as well as other measures of financial sophistication. The SEC defines an accredited investor as: 
  • Net worth over $1 million, excluding primary residence (individually or with spouse or partner).
  • Income over $200,000 (individually) or $300,000 (with spouse or partner) in each of the prior two years, and reasonably expects the same for the current year.

Professional Criteria

  • Investment professionals in good standing holding the general securities representative license (Series 7), the investment adviser representative license (Series 65), or the private securities offerings representative license (Series 82).
  • Directors, executive officers, or general partners (GP) of the company selling the securities (or of a GP of that company).
  • Any “family client” of a “family office” that qualifies as an accredited investor.
  • For investments in a private fund, “knowledgeable employees” of the fund.

Contact